Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Noninferiority Trials in Drug Development: Clinical, Statistical and Regulatory Perspectives
Track : Track 15: Statistical Science and Quantitative Thinking
Program Code: 383
Date: Wednesday, June 26, 2013
Time: 4:00 PM to 5:30 PM  EST
Location: 157AB
CHAIR :
 Surya P. Chitra, PhD,MBA (SCHNON), Director, Biostatistics, Endo Health Solutions, United States
SPEAKER (S):
Yusong Chen, PhD (SPKNON), Endo Health Solutions, United States
 Ram Tiwari, PhD (SCHAGY), Associate Director, Office of Biostatistics, OTS, CDER, FDA, United States
 Ulysses A. Diva, PhD (SPKNON), Principal Statistician, Bioinformatics and Information Sciences, AstraZeneca, United States
Description
Increasing trends in conducting noninferiority trials in drug development will continue as more drugs are approved. Although this trend will make interpretation of trial results more challenging, it can provide opportunities for new outcomes for patients.

Session Recording
(Code: 383)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 383)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Noninferiority Trials in Drug Development: Clinical, Statistical and Regulatory Perspectives